Bio-Rad Launches PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers

The PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers are the latest additions to the Bio-Rad portfolio of conventional PCR thermal cyclers.


Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced the launch of its PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers, designed to support PCR applications in basic and translational research, process development, and quality control.

PTC Tempo 48/48 Thermal Cycler
PTC Tempo 48/48 Thermal Cycler
Bio-Rad

The PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers are the latest additions to the Bio-Rad portfolio of conventional PCR thermal cyclers. The PTC Tempo Thermal Cyclers are built with a refreshed, intuitive user interface and flexible connectivity features for streamlining protocol management, including monitoring capabilities on the BR.io cloud platform. Engineered to maintain superior thermal performance, the PTC Tempo Thermal Cyclers offer scientists the flexibility to scale within the laboratory.

The PTC Tempo 48/48 Thermal Cycler features separate dual blocks with manual lids, allowing two independent protocols to run simultaneously. Optimized for laboratories working with higher sample throughput, the PTC Tempo 384 Thermal Cycler features a motorized lid for automation compatibility and integration with robotics.

“We are excited to bring the PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers to the market, expanding the PTC Tempo family and completing the refresh of the 1000-Series Thermal Cyclers for research use,” said Steven Blakely, Senior Director of Marketing for Bio-Rad’s gene expression business.These PCR instruments offer enhanced usability with features designed to support academic, commercial, and biopharma labs.”

Keywords

Share
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo